The Prostate Cancer Foundation has announced grants totaling $6 million to six teams of investigators conducting innovative research on treatments and cures for prostate cancer.
Rick Kittles joined City of Hope as professor and founding director of the Division of Health Equities within the Department of Population Sciences. Kittles' research focuses on understanding the complex issues surrounding race, genetic ancestry and disease, particularly health disparities among different ethnicities.His work focuses on research into prostate cancer and health disparities among African-Americans, a field of study motivated by his grandfather's late-stage prostate cancer diagnosis and subsequent death while Kittles was in graduate school.“It was just so shocking and quick how it happened,” he recalled. “I had no idea it was such a big issue in the black community.”
William Dale joined City of Hope as a clinical professor in the Department of Supportive Care Medicine.Dale is a board-certified geriatrician and palliative medicine physician with a doctorate in health policy. He completed his medical and graduate school training at the University of Chicago and did his residency in internal medicine and fellowship training in geriatrics at the University of Pittsburgh.
Deric Savior has been promoted to head of medical oncology at Fox Chase Cancer Center at Temple University Hospital.
Carlyn Tan has joined the department of hematology/oncology at Fox Chase Cancer Center.
Reza Nejati was hired as a hematopathologist in the department of pathology at the Fox Chase Cancer Center.
The Cancer Prevention and Research Institute of Texas awarded 60 new academic research, centered around cancer prevention, and product development research grants totaling more than $102 million.CPRIT has awarded 1,189 grants totaling more than $1.89 billion. The agency began making awards in 2009 after Texas voters overwhelmingly approved a 2007 constitutional amendment committing $3 billion to the fight against cancer. Fifty-one of the awards, totaling more than $79 million, went to academic research grants/ Eight prevention services grants were awarded totaling $14 million, as well as one product development research grant for $9 million.“The large number of awards approved by CPRIT underlies the growth of the cancer-fighting ecosystem in Texas,” said Wayne Roberts, CPRIT chief executive officer. “This momentum is evident as Texas expands its critical mass of talent in our life-sciences sector.”
Ramon Parsons was named director of the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai effective July 1.
The American Society for Radiation Oncology selected 23 members to receive the ASTRO Fellow designation.
Emmanuel Quien has joined the Fox Chase cancer Center Department of Hematology/Oncology.
